Ricevimento previa appuntamento contattando l'indirizzo linda.vignozzi@unifi.it
Professoressa Linda Vignozzi
La Prof.ssa Linda Vignozzi è nata a Empoli il 05/01/1976 e si è laureata in Medicina e Chirurgia presso l’Università degli Studi di Firenze nel 2001, con il massimo dei voti e la Lode. Nel 2006 ha conseguito il titolo di Dottore di Ricerca in Endocrinologia e Malattie del Metabolismo presso l’Università degli Studi di Firenze e nel 2011 quello di Specialista in Endocrinologia e Malattie del Metabolismo presso l’Università degli Studi di Pisa.
Da Luglio 2015 è Professore Associato in Endocrinologia presso la Facoltà di Medicina e Chirurgia di Firenze nel Dipartimento di Scienze Biomediche, sperimentali e cliniche “Mario Serio”. E’ stata Coordinatrice di unità all’interno di Progetti di Ricerca di interesse nazionale (PRIN e FIRB). Ad oggi coordina l’unità di Ricerca in Endocrinologia ginecologica all’interno della sezione di Medicina della Sessualità e Andrologia dell’Università degli Studi di Firenze. Vice-Presidente del Corso di Laurea in Medicina e Chirurgia di Firenze. Riveste anche il ruolo di membro del Senato Accademico dell’Università di Firenze.
La Prof.ssa Vignozzi ha rivestito numerose cariche in commissioni scientifiche all’interno di diverse società nazionali ed internazionali in ambito endocrinologico, come la SIAMS e la SIE ed è attualmente Presidente eletto della Società Italiana di Andrologia e Medicina della sessualità (SIAMS) e Presidente eletto di ISSWSH -International Society for the Study of Women's Sexual Health. Ha ricoperto la funcione di Membro del Consiglio Direttivo della Società Italiana di Endocrinologia fino al 2021. E’ inoltre il coordinatore della sottocommissione della International Society for Sexual Medicine (ISSM) dedicata alla “Female Sexual (dys)function” e il coordinatore della Commissione Scientifica per la “Female Sexual Health dysfunction” dell’European Society for Sexual Medicine (ESSM). E’ Deputy Editor-in-Chief del Journal of Sexual Medicine e membro del pannello editoriale di riviste scientifiche internazionali in ambito endocrinologico. Svolge inoltre regolarmente attività di revisore per le maggiori riviste scientifiche del settore e per agenzie di finanziamento nazionali e internazionali. La Professoressa Vignozzi ha pubblicato più di 180 lavori su riviste internazionali con peer-review nell’ambito della fisiopatologia della riproduzione e della sessualità maschile e femminile, e delle malattie metaboliche ad essa correlate. La produzione scientifica è ampiamente citata con un H-index di 60 su Scopus-(Scopus - Author search results; https://www.scopus.com/authid/detail.uri?authorId=6507526011). Dal 2004 la Prof.ssa è stata invited speaker in numerosi congressi scientifici di rilevanza nazionale e internazionale.
Attualmente Dirige la SOD complessa di Andrologia, Endocvrinologia femminile e Incongruenza di genere-AOU Careggi, Firenze.
Linda Vignozzi
Place and Date of Birth: Empoli (Florence, Italy), January 05, 1976
e-mail: linda.vignozzi@unifi.it
mobile phone: +39 3666686732
ORCID ID: orcid.org/0000-0003-0907-0630
CURRENT POSITION: ASSOCIATE PROFESSOR IN ENDOCRINOLOGY AT THE UNIVERSITY OF FLORENCE, FLORENCE, ITALY; DIRECTOR OF "Andrology, women's endocrinology and gender incongruence unit"-Careggi Hospiyal, Florence Italy
Until now she has been recipient as Unit coordinator of two Research Projects funded by:
1-PRIN (Programmi di ricerca di Rilevante Interesse Nazionale) of the Italian Minister of University, Research and Instruction” Effects of hypogonadism and testosterone supplementation on cardiovascular function in an experimental model of chronic heart failure”(Year 2009- prot. 2009WLNXNT_002),
2- FIRB (Programma Futuro in Ricerca) of the Italian Minister of University, Research and Instruction” Study of the role of metabolic syndrome in the pathogenesis of male infertility" (Year 2010-prot. RBFR10VJ56_002).
Education:
n 1994 Graduated from high school (Liceo Scientifico score 60/60)
n 2001 Master Degree in Medical Science score 110 cum laude/110 -University of Florence
n 2002 Professional Abilitation
n 2006 PhD Degree in Endocrinological and Metabolic Science - University of Florence
n 2011 Postgraduate Diplomate at the School of Endocrinology and Metabolism- University of Pisa
2001-2002: Fellow Researcher Assistant at the Dept. of Clinical Pharmacology, University of Florence, Italy
2002: Researcher Assistant at Dept. Clinical Physiopathology, University of Florence, Italy
2003-2005: PhD student at Dept. Clinical Physiopathology, University of Florence, Italy
2006 fellow recipient of a special research grant from BioXell, Milan, Italy
2006-2009 student at the post-graduated school of Endocrinology and Metabolic disease, University of Florence, Italy
Since 2003 Teacher at the Course of Sexual Medicine, University of Florence, Italy.
Since 2011 Teacher at the Postgraduate School of Endocrinology and Metabolism- University of Florence, Italy
Co-Coordinator of II level Master Degree Course of “Andrology and Sexual Medicine“, University of Florence, (from 2015 at present)
Co-Coordinator of II level Master Degree Course of “Biology and technologies for reproduction“ at the University of Florence (from 2019 at present)
Principal Coordinator of I level Master Degree Course of “ Gender Incongruence”, University of Florence (from 2019 at present)
Chair of the Exam Committee for the Multidisciplinary Joint Committee for Sexual medicine (MJCSM). The Exam has received the appraisal and approval of the UEMS-CESMA. Prof. Vignozzi has been in charge for the appraisal procedure (from 2018 at present).
Director of the Andrology, Women’s Endocrinology and Gender Incongruence Unit at Careggi Hospital, Florence, Italy (Since November 2018)
Vice President of the School of Medicine and Surgery - University of Florence, (from 2018 at present)
Vice-General Secretary and Member of the Committee “Pedagogic Innovation in Medical Education” of the National Permanent Conference of the Presidents of the School of Medicine and Surgery - CPPCLMMC (from 2019 at present)
Member of the “General Educational Committee” of the University of Florence (from 2019 at present)
Invited teaching activity at the University of Ghent, with lecture at the Post-graduate Course of Endocrinology (April 2020)
Scientific Societies
Editorial activity:
Invited Speaker:
* Invited Speaker on “Pathophysiology and molecular biology of erection”. VI° National Congress of the Italian Society of Medical Andrology, Naples 7-9 October 2004
* Invited Speaker on “ Hypogonadism and metabolic alteration”. Congress of the Italian Society of Andrology and Italian Society of Medical Andrology on Gonadal Pathology, Rome 20-21 January 2006
* Invited Speaker on “ Role of testosterone treatment in Klinefelter syndrome”. Congress “Diagnosis and treatment of Klinefelter Syndrome Pisa 20 November 2010
* Invited Speaker on “ Role of testosterone treatment in hypogonadism”. Congress “Klinefelter Syndrome and secondary hypoganism” Udine 17 September 2010
* Invited Speaker on “Diagnosis of hyperandrogenism in female” Post-graduated Course of Gynecology in the Infancy and Adolescence Florence 14 February 2011
* Invited Speaker on “Sexuality in Klinefelter syndrome”. Congress “Klinefelter Syndrome” Bari 12 March 2011
* Invited Speaker on “Sexuality in Klinefelter syndrome”. Congress “Klinefelter Syndrome” Genova 18 June 2011
* Invited Speaker on “PDE5inhibitors in LUTS”. Congress “Controversie in Andrologia” Rome 24 June 2011
* Invited speaker at the XIV Congress of the European Society for Sexual Medicine "Early puberty and delayed puberty"- 1-4 december 2011-Milan Italy.
* Invited Speaker on “Testosterone and sexual function””. Congress “30 anni di Andrologia” Rome 15-16 June 2012
* Invited Speaker on “Neurobiological regulation of female sexuality”. National Congress of the Italian Society of Sexual Medicine, Lecce, November 2012.
* Invited Speaker on “Unconventional Use of PDE5inhibitors: anti-inflammatory effects” 16th ESSM Congress European Society of Sexual Medicine29 January – 1 February 2014 in Istanbul, Turkey
* Invited Speaker on “Prostate inflammation as a new metabolic syndrome-related disorder: role for PDE5 inhibitors” 16th Urinary Tract and Prostate Symposium- Tokyo, Japan, 19 January 2014
* Invited speaker on “Diagnosis of hirsutism” at the XII Course of Childhood and Adolescence Gynecology, Florence 25 february 2014
* Invited speaker at the Congress of the European Academy of Andrology:, Barcelona 15-17 October 2014, on “Benign Prostatic hyperplasia: a new metabolic syndrome-related disease”
* Invited speaker at the national congress of Italian Society of Andrology and Sexual Medicine, Cagliari 13-15 november 2014 on “Erectile dysfunction and BPH: beyond the uro-genital tract”.
* Invited speaker at the Congress SIAMS “L’andrologo: il medico dell’upomo per tutte le età” Catanzaro 27-28 marzo 2015 on “ Uso cronico dei PDE5 inibitori dalla ricerca di base alla clinica”
* Invited Speaker at the National Congress of Endocrinology, Taormina, Italy 27-30 May 2015 “ Metabolic syndrome and Reproduction”
* Invited Speaker at the Congress “ Obesity Work in progress”, Pisa 20-21 November 2016 “Testosterone and obesity: experimental evidence”
* Invited Speaker at European Congress of Andrology, Rotterdam 21--23 September 2016 “Testosterone, inflammation and auto-immune diseases–what is old and what is new?”
* Invited Speaker at European Congress of Andrology, Rotterdam 21-23 September 2016 “Metabolic syndrome, systemic inflammation and erectile dysfunction”
* Invited Speaker at National Congress of the Italian Society of Andrology and Sexual Medicine Rome 1-3 December 2016 “Pubertà femminile: endocrinologia e sessualità”
* Invited Speaker at the Congress “Ginecologia dell’Infanzia e Adolescenza” Florence 20/22 March “Role of inflammation in PCOS”
* Invited Speaker at the International congress of andrology Copenhagen, Denmark 6-9 May 2017 “novel risk associations for LUTS/BPH and erectile dysfunction”
* Invited Speaker at the National Congress of the Italian society of Endocrinology 20-23 June 2017 “Menopause and cardio-metabolic risk: guide to the use of estroprogestins”
SCIENTIFIC PUBLICATIONS
1) Granchi S., Vannelli GB., Vignozzi L., Crescioli C., Ferruzzi P., Mancina R., Vinci MC., Forti G, Filippi S., Ledda F., Maggi M. Expression and regulation of Endothelin-1 and its receptors in human penile smooth muscle cells. Mol Human Reprod 8: 1053-1064, 2002.
2) Filippi S., Luconi M., Granchi S., Vignozzi L., Bettuzzi S., Tozzi P., Ledda F., Maggi M. Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. Endocrinology 143:4543, 2002.
3) Filippi S., Vannelli G. B., Granchi S., Luconi M., Crescioli C., Mancina R., Natali A., Brocchi S., Vignozzi L., Bencini E., Noci I., Ledda F., Forti G. Maggi M. Identification, localization and functional activity of oxytocin receptors in epididymis. Mol and Cell. Endocrinology 193: 89-100, 2002.
4) Filippi S., Vignozzi L., Vannelli G. B., Ledda F., Forti G. Maggi M., Role of oxytocin in the ejaculatory process. J Endocrinol Invest, 26:82-86, 2003.
5) Filippi S., Marini M., Vannelli GB., Crescioli C., Granchi S., Vignozzi L., Luconi M., Ferruzzi P., Morelli A., Forti G., Ledda F., Maggi M. Effect of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. Mol Human Reprod 9:765-74, 2003.
6) Vignozzi L., Filippi S., Luconi M., Morelli A., Mancina R., Marinii M., Vannelli GB., Gelmini S., Orlando C., Ledda F., Forti G., Maggi M. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology 145:1823-1834, 2004.
7) Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa Endocrinology 145:2253-2263, 2004.
8) Vignozzi L., Vannelli G.B., Morelli A., Mancina R., Marini M., Ferruzzi P., Crescioli C., Luconi M., Donati S., Fisher A., Baldi E., Filippi S., Forti G. & Maggi M. Identification, characterization and biological activity of oxytocin receptor in the developing human penis. Mol Hum Repr 11: 99-106, 2005.
9) Mancina R., Filippi S., Marini M., Morelli A., Vignozzi L., Salonia A., Montorsi F., Mondani N., Vannelli G.B., Donati S., Lotti F., Forti G. & Maggi M. Expression And Functional Activity of Phosphodiesterase Type 5 In Human And Rabbit Vas Deferens. Mol Hum Repr 11:107-115, 2005.
10) Zhang X.H., Filippi S., Vignozzi L., Mancina R., Luconi M., Marini M., Vannelli G.B., Forti G. & Maggi M. Identification, localization and functional “in vitro” and “in vivo” activity of oxytocin receptor in the rat penis. J Endocrinol 184:567-576, 2005.
11) Zhang X.H., Morelli A., Luconi M., Vignozzi L., Filippi S., Marini M., Vannelli G.B., Mancina R., Forti G. & Maggi M. Testosterone Regulates PDE5 Expression and in vivo Responsiveness to Tadalafil in Rat Corpus Cavernosum. European Urology 47:409-416, 2005.
12) Vignozzi L., Corona G., Petrone L., Filippi S., Morelli A., Forti G. & Maggi M. Testosterone and sexual activity. J Endocrinol Invest 28(Suppl. 3):39-44, 2005.
13) Morelli A, Filippi S, Zhang XH, Luconi M, Vignozzi L, Mancina R, Maggi M. Peripheral regulatory mechanisms in erection. Int J Androl 28:23-27, 2005.
14) Filippi S., Morelli A., Vignozzi L., Vannelli G.B., Marini M., Ferruzzi P., Mancina R., Crescioli C., Mondani N., Forti G., Ledda F. & Maggi M. Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. Endocrinology 146: 3506-3517, 2005.
15) A. Morelli, L.Vignozzi, S. Filippi, R. Mancina & M. Maggi. Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. Minerva Urol Nefrol 57:85-90, 2005.
16) XH Zhang, S Filippi, A Morelli, L Vignozzi, M Luconi, S Donati, G Forti, M Maggi. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 3: 253-266, 2006.
17) Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med 3:419-31, 2006.
18) Morelli A, Vignozzi L, Sandra Filippi, Gabriella B. Vannelli, Stefano Ambrosini, Rosa Mancina, Clara Crescioli, Silvia Donati, Benedetta Fibbi, Enrico Colli, Luciano Adorini, Mario Maggi. BXL-628, a Vitamin D Receptor Agonist Effective in Benign Prostatic Hyperplasia Treatment, Prevents RhoA Activation and Inhibits RhoA/Rho Kinase Signalling in Rat and Human Bladder. The Prostate 67:234-47, 2007.
19) Morelli A, Corona G, Vignozzi L, Filippi S, Forti G, Maggi M. Which patients with sexual dysfunction are suitable for testosterone replacement therapy? J Endocrinol Invest 30:880-8, 2007.
20) Vignozzi L, Morelli A, Filippi S, Vannelli GB, Mungai S, Marini M, Boddi V, Forti G, Maggi M. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res 20:60-7, 2008.
21) Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L, Filippi S, Chavalmane A, Silvestrini E, Colli E, Adorini L, Vannelli GB, Maggi M. Atorvastatin but not elocalcitol increases sildenafil responsiveness in Spontaneously Hypertensive Rats by regulating the RhoA/ROCK pathway. J Androl 29:70-84, 2008.
22) Vignozzi L, Morelli A, Filippi S, Ambrosini S, Mancina R, Luconi M, Mungai S, Vannelli GB, Zhang XH, Forti G, Maggi M. Testosterone regulates RhoA/Rho-kinase signalling in two distinct animal models of chemical diabetes. J Sex Med 4:620-30, 2007.
23) Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M, Forti G, Maggi M. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148:1019-29, 2007.
24) Morelli A, Marini M, Mancina R, Luconi M, Vignozzi L, Fibbi B, Filippi S, Pezzatini A, Forti G, Vannelli GB, Maggi M. Sex Steroids and Leptin Regulate the "First Kiss" (KiSS 1/G-Protein-Coupled Receptor 54 System) in Human Gonadotropin-Releasing-Hormone-Secreting Neuroblasts. J Sex Med 5:1097-1113, 2008.
25)Morelli A, Squecco R, Failli P, Filippi S, Vignozzi L, Chavalmane AK, Fibbi B, Mancina R, Luciani G, Gacci M, Colli E, Francini F, Adorini L, Maggi M. The vitamin D receptor agonist elocalcitol up-regulates L-type calcium channel activity in human and rat bladder. Am J Physiol Cell Physiol 294:C1206-14, 2008.
26)Corona G, Mannucci E, Fisher AD, Lotti F, Bandini E, Vignozzi L, Balercia G, Paggi F, Petrone L, Forti G, Maggi M. Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound. J Endocrinol Invest 31:1058-62, 2008.
27)Vignozzi L, Filippi S, Morelli A, Luconi M, Forti G, Maggi M. Regulation of epididymal contactility during semen emission, the first part of the ejaculatory process: a role for estrogen. J Sex Med 5:2010-6, 2008.
28)Morelli A, Fibbi B, Marini M, Silvestrini E, De Vita G, Chavalmane AK, Vignozzi L, Filippi S, Forti G, Vannelli GB, Maggi M. Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts. J Sex Med 6:397-407, 2009.
29)Vignozzi L, Morelli A. Editorial Comment on: Intravesical Botulinum Toxin A Administration Inhibits COX-2 and EP4 Expression and Suppresses Bladder Hyperactivity in Cyclophosphamide-Induced Cystitis in Rats. Eur Urol 56:166, 2009.
30)Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E, Zhang XH, Vignozzi L, Vannelli GB, Forti G, Maggi M. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signalling hyperactivation. J Sex Med 6:91-106, 2009.
31)Vignozzi L, Filippi S, Morelli A, Marini M, Chavalmane A, Fibbi B, Silvestrini E, Mancina R, Carini M, Vannelli GB, Forti G, Maggi M. Cavernous Neurotomy in the Rat is Associated with the Onset of an Overt Condition of Hypogonadism. J Sex Med 6:1270-83, 2009.
32)Morelli A, Filippi S, Sandner P, Fibbi B, Chavalmane AK, Silvestrini E, Sarchielli E, Vignozzi L, Gacci M, Carini M, Vannelli GB, Maggi M. Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats J Sex Med 6:1594-608, 2009.
33)Fibbi B, Filippi S, Morelli A, Vignozzi L, Silvestrini E, Chavalmane A, De Vita G, Marini M, Gacci M, Manieri C, Vannelli GB, Maggi M. Estrogens Regulate Humans and Rabbit Epididymal Contractility Through the RhoA/Rho-kinase Pathway. J Sex Med 6:2173-86, 2009.
34)Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A, Vignozzi L, Balercia G, Sforza A, Forti G, Mannucci E and Maggi M. Sexual dysfunctions in subjects with Klinefelter’s syndrome. Int J Androl 33:574-80, 2010.
35)Filippi S, Vignozzi L (equally contributed as first author), Morelli A, Chavalmane AK, Sarchielli E, Fibbi B, Saad F, Sandner P, Ruggiano P, Vannelli GB, Mannucci E, Maggi M. Testosterone partially ameliorates metabolic profile and erectile responsiveness to pde5 inhibitors in an animal model of male metabolic syndrome. J Sex Med 6:3274-88, 2009.
36)Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P, Maggi M. Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract. J Sex Med 7:59-69, 2010.
37)Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, Corona G, Lenzi A, Jannini EA. Development and Validation of a 6-Item Version of the Female Sexual Function Index (FSFI) as a Diagnostic Tool for Female Sexual Dysfunction. J Sex Med 7:1139-46, 2010.
38)Morelli A, Filippi S, Comeglio P, Sarchielli E, Chavalmane AK, Vignozzi L, Fibbi B, Silvestrini E, Sandner P, Gacci M, Carini M, Vannelli GB, Maggi M. Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats. J Sex Med 7:107-20, 2010.
39)Vignozzi L, Corona G, Jannini EA, Maggi M. Clinical and Therapeutic aspects of Klinefelter’s sindrome: sexual function. Mol Hum Reprod 16:418-24, 2010.
40) Comeglio P, Chavalmane AK, Fibbi B, Filippi S, Marchetta M, Marini M, Morelli A, Penna G, Vignozzi L, Vannelli GB, Adorini L, Maggi M. Human prostatic urethra expresses Vitamin D receptor and responds to Vitamin D receptor ligation. J Endocrinol Invest 33:730-8, 2010.
41) Chavalmane AK, Comeglio P, Morelli A, Filippi S, Fibbi B, Vignozzi L, Sarchielli E, Marchetta M, Failli P, Sandner P, Saad F, Gacci M, Vannelli GB, Maggi M. Sex Steroid Receptors in Male Human Bladder: Expression and Biological Function. J Sex Med 7:2698-713, 2010.
42) Vignozzi L, Morelli A, Filippi S, Maggi M, Forti G. Male pubertal development: role of androgen therapy on bone mass and body composition. J Endocrinol Invest 33:27-32, 2010.
43) Radicioni AF, Balercia G., Ferlin A. Pasquali M. D., Vignozzi L., Maggi M, Foresta C., Lenzi A. Consensus Statement on Diagnosis and Clinical Management of Klinefelter Syndrome. J Endocrinol Invest 33:839-50, 2010.
44) Corona G, Rastrelli G, Vignozzi L, Mannucci E and Mario Maggi. Testosterone, cardiovascular disease and the metabolic sindrome. Best Pract Res Clin Endocrinol Metab 25:337-53, 2011.
45) Vignozzi L, Morelli A, Filippi S, Comeglio P, Chavalmane AK, Marchetta M, Toce M, Yehiely-Cohen R, Vannelli GB, Adorini L, Maggi M. Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. J Sex Med 8:57-77, 2011.
46) Forti G, Corona G, Vignozzi L, Krausz C, Maggi M. Klinefelter's syndrome: a clinical and therapeutical update. Sex Dev 4:249-58, 2010.
47) Morelli A, Vignozzi L, Maggi M, Adorini L. Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes. Biochim Biophys Acta 1812:859-66, 2011.
48) Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E, Maggi M. Hypogonadism and Metabolic Syndrome. J Endocrinol Invest 34:557-67, 2011.
49) Morelli A, Sarchielli E, Comeglio P, Filippi S, Mancina R, Gacci M, Vignozzi L, Carini M, Vannelli GB, Maggi M. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues, and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. J Sex Med 8:2746-60, 2011.
50) Vignozzi L, Morelli A, Sarchielli E, Comeglio P, Filippi S, Cellai I, Maneschi E, Gacci M, Serni S, Carini M, Piccinni MP, Saad F, Adorini L, Vannelli GB, Maggi M. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. J Endocrinol 212:71-84, 2012.
51) Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J Androl 14:251-9, 2012.
52) Gacci M, Corona G, Salvi M, Vignozzi L, McVary KT, Kaplan SA, Roehrborn CG, Serni S, Mirone V, Carini M, Maggi M. A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 61:994-1003, 2012.
53) Morelli A, Comeglio P, Filippi S, Sarchielli E, Cellai I, Vignozzi L, Yehiely-Cohen R, Maneschi E, Gacci M, Carini M, Adorini L, Vannelli GB, Maggi M. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. J Steroid Biochem Mol Biol 132:80-92, 2012.
54) Gacci M, Vittori G, Tosi N, Siena G, Rossetti MA, Lapini A, Vignozzi L, Serni S, Maggi M, Carini M. A Randomized, Placebo-Controlled Study to Assess Safety and Efficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Sex Med 9:1624-33, 2012.
55) Vignozzi L, Cellai I, Santi R, Lombardelli L, Morelli A, Comeglio P, Filippi S, Logiodice F, Carini M, Nesi G, Gacci M, Piccinni MP, Adorini L, Maggi M. Anti-inflammatory effect of androgen receptor activation in human BPH cells. J Endocrinol 214:31-43, 2012.
56) Corona G, Rastrelli G, Vignozzi L, Maggi M. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs 17:239-59, 2012.
57) Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol 9:508-19, 2012.
58) Castellini G, Lelli L, Lo Sauro C, Fioravanti G, Vignozzi L, Maggi M, Faravelli C, Ricca V. Anorectic and bulimic patients suffer from relevant sexual dysfunctions. J Sex Med 9:2590-9, 2012.
59) Castellini G, Lelli L, Lo Sauro C, Vignozzi L, Maggi M, Faravelli C, Ricca V. Childhood abuse, sexual function and cortisol levels in eating disorders. Psychother Psychosom 81:380-2, 2012.
60) Morelli A, Comeglio P, Filippi S, Sarchielli E, Vignozzi L, Maneschi E, Cellai I, Gacci M, Lenzi A, Vannelli GB, Maggi M. Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. Prostate 73:428-41, 2013
61) Maneschi E, Morelli A, Filippi S, Cellai I, Comeglio P, Mazzanti B, Mello T, Calcagno A, Sarchielli E, Vignozzi L, Saad F, Vettor R, Vannelli GB, Maggi M. Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. J Endocrinol 215:347-362, 2012.
62) Vignozzi L, Filippi S, Morelli A, Comeglio P, Cellai I, Sarchielli E, Maneschi E, Mancina R, Gacci M, Vannelli GB, Maggi M. Testosterone/Estradiol Ratio Regulates NO-Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors. J Sex Med 9:3028-40, 2012.
63) Vignozzi L, Morelli A, Corona G, Sebastianelli A, Serni S, Gacci M, Adorini L, Maggi M. Testosterone protects the lower urinary tract from metabolic syndrome-induced alterations. Hormo Mol Biol Clin Invest 11: 329-337, 2012.
64) Gacci M, Vignozzi L (contributing as first author), Sebastianelli A, Salvi M, Giannessi C, De Nunzio C, Tubaro A, Corona G, Rastrelli G, Santi R, Nesi G, Serni S, Carini M, Maggi M. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis 16:101-6, 2013.
65) Corona G, Rastrelli G, Ricca V, Jannini EA, Vignozzi L, Monami M, Sforza A, Forti G, Mannucci E, Maggi M. Risk Factors Associated with Primary and Secondary Reduced Libido in Male Patients with Sexual Dysfunction. J Sex Med 10:1074-89, 2013.
66) Lotti F, Corona G, Degli Innocenti S, Filimberti E, Scognamiglio V, Vignozzi L, Forti G, Maggi M. Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples. Andrology 1:229-39, 2013.
67) Vignozzi L, Gacci M, Cellai I, Santi R, Corona G, Morelli A, Rastrelli G, Comeglio P, Sebastanelli A, Maneschi E, Nesi G, De Nunzio C, Tubaro A, Mannucci E, Carini M, Maggi M. Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. Prostate 73:789-800, 2013.
68) Vignozzi L, Gacci M, Cellai I, Morelli A, Maneschi E, Comeglio P, Santi R, Filippi S, Sebastianelli A, Nesi G, Serni S, Carini M, Maggi M. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. Prostate 73:1391-402, 2013.
69) Maneschi E, Vignozzi L (contributing as first author), Morelli A, Mello T, Filippi S, Cellai I, Comeglio P, Sarchielli E, Calcagno A, Mazznti B, Vettor R, Vannelli GB, Adorini L, Maggi M. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. J Endocrinol 218:215-31, 2013.
70) Gacci M, Tosi N, Vittori G, Minervini A, Corona G, Cai T, Morelli A, Vignozzi L, Serni S, Maggi M, Carini M. Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. Oncology Letters 6:529-533, 2013.
71) Gacci M, Salvi M, Sebastianelli A, Vignozzi L, Corona G, McVary K, Kaplan S, Maggi M, Carini M, Oelke M. The use of a single daily dose of tadalafil to treat signis and symtoms of benign prostatic hyperplasia and erectile dysfunction. Research and Reports in Urology 5: 1-13, 2013.
72) Castellini G, Lo Sauro C, Lelli L, Godini L, Vignozzi L, Rellini AH, Faravelli C, Maggi M, Ricca V. Childhood Sexual Abuse Moderates the Relationship Between Sexual Functioning and Eating Disorder Psychopathology in Anorexia Nervosa and Bulimia Nervosa: A 1-Year Follow-Up Study. J Sex Med 10:2190-200, 2013.
73) Morelli A, Sarchielli E, Comeglio P, Filippi S, Vignozzi L, Marini M, Rastrelli G, Maneschi E, Cellai I, Persani L, Adorini L, Vannelli GB, Maggi M. Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Mol Cell Endocrinol 382:107-119, 2014.
74) Corona G, Vignozzi L, Sforza A, Maggi M. Risks and benefits of late onset hypogonadism treatment: an expert opinion. World J Mens Health 31:103-25, 2013.
75) Gacci M, Sebastianelli A, Salvi M, Vignozzi L, Corona G, McVary KT, Kaplan SA, Oelke M, Maggi M, Carini M. PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH. Curr Bladder Dysfunct Rep 8:150-159, 2013.
76) Comeglio P, Morelli A, Cellai I, Vignozzi L, Sarchielli E, Filippi S, Maneschi E, Corcetto F, Corno C, Gacci M, Vannelli GB, Maggi M. Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? Prostate 74:10-28, 2014.
77) Rastrelli G, Corona G, Vignozzi L, Maseroli E, Silverii A, Monami M, Mannucci E, Forti G, Maggi M. Serum PSA as a Predictor of Testosterone Deficiency. J Sex Med 10:2518-28, 2013.
78) Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Maneschi E, Sarchielli E, Gacci M, Carini M, Vannelli GB, Maggi M. Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. J Sex Med 11:1159-72, 2014.
79) Vignozzi L., Filippi S., Comeglio P., Cellai I., Sarchielli I., Morelli A., Rastrelli G., Maneschi E., Galli A., Vannelli GB, Saad Farid, Mannucci E., Adorini L., Maggi M. Nonalcoholic steatohepatitis as a novel player in metabolic sindrome-induced erectile dysfunction: an experimental study in the rabbit. Mol and Cell Endocrinology 384:143-54, 2014.
80) Morelli A, Comeglio P, Sarchielli E, Cellai I, Vignozzi L, Vannelli GB, Maggi M. Negative effects of high glucose exposure in human gonadotropin-releasing hormone neurons. Int J Endocrinol 2013:684659, 2013.
81) Vignozzi L, Rastrelli G, Corona G, Gacci M, Forti G, Maggi M. Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 37:313-22, 2014.
82) Vignozzi L, Maggi M. Prostate cancer: Intriguing data on inflammation andprostate cancer. Nat Rev Urol 11:369-70, 2014.
83) Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Rastrelli G, Maneschi E, Mannucci E, Maggi M. Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. J Sex Med 11:1694-708, 2014.
84) Corona G, Gacci M, Maseroli E, Rastrelli G, Vignozzi L, Sforza A, Forti G, Mannucci E, Maggi M. Clinical correlates of enlarged prostate size in subjects with sexual dysfunction. Asian J Androl 16:767-73, 2014.
85) Gacci M, Carini M, Salvi M, Sebastianelli A, Vignozzi L, Corona G, Maggi M, McVary KT, Kaplan SA, Oelke M, Serni S. Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors. Drugs Aging 31:425-39, 2014.
86) Corona G, Rastrelli G, Filippi S, Vignozzi L, Mannucci E, Maggi M. Erectile dysfunction and central obesity: an Italian perspective. Asian J Androl 16:581-91, 2014.
87) Corona G, Vignozzi L, Rastrelli G, Lotti F, Cipriani S, Maggi M. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol 2014:329456, 2014.
88) Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M. Metabolic Syndrome and Benign Prostatic Enlargement: A Systematic Review and Meta-Analysis. BJU Int 115:24-31, 2015.
89) Marchiani S, Vignozzi L, Filippi S, Gurrieri B, Comeglio P, Morelli A, Danza G, Bartolucci G, Maggi M, Baldi E. Metabolic syndrome-associated sperm alterations in an experimental rabbit model: Relation with metabolic profile, testis and epididymis gene expression and effect of tamoxifen treatment. Mol Cell Endocrinol 401:12-24, 2015.
90) Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Marchetta M, Maggi M. Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. J Sex Med 11:2890-902, 2014.
91) Lotti F, Corona G, Vignozzi L, Rossi M, Maseroli E, Cipriani S, Gacci M, Forti G, Maggi M. Metabolic syndrome and prostate abnormalities in male subjects of infertile couples. Asian J Androl 16:295-304, 2014.
92) Maseroli E, Fanni E, Fambrini M, Ragghianti B, Limoncin E, Mannucci E, Maggi M, Vignozzi L. Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction. J Endocrinol Invest 401:12-24, 2015.
93) Corona G, Vignozzi L, Sforza A, Mannucci E, Maggi M. Obesity and late-onset hypogonadism. Mol Cell Endocrinol 418:120-33, 2015.
94) Nasser M, Haider A, Saad F, Kurtz W, Doros G, Fijak M, Vignozzi L, Gooren L. Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study. Horm Mol Biol Clin Investig 22:111-7, 2015.
95) Gacci M, Sebastianelli A, Salvi M, De Nunzio C, Tubaro A, Vignozzi L, Corona G, McVary KT, Kaplan SA, Maggi M, Carini M, Serni S. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. BJU Int 116:271-7, 2015.
96) Corona G, Pizzocaro A, Lanfranco F, Garolla A, Pelliccione F, Vignozzi L, Ferlin A, Foresta C, Jannini EA, Maggi M, Lenzi A, Pasquali D, Francavilla S; Klinefelter ItaliaN Group (KING). Sperm recovery and ICSI outcomes in Klinefelter syndrome: a systematic review and meta-analysis. Hum Reprod Update 23:265-275, 2017.
Gacci M, Sebastianelli A, Salvi M, De Nunzio C, Vignozzi L, Corona G, Jaeger T, Chini T, Russo GI, Maggi M, Morgia G, Tubaro A, Carini M, Serni S. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol 17:22, 2017.
Calogero AE, Giagulli VA, Mongioì LM, Triggiani V, Radicioni AF, Jannini EA, Pasquali D; Klinefelter ItaliaN Group (KING). Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. J Endocrinol Invest 40:705-712, 2017.
Gacci M, Russo GI, De Nunzio C, Sebastianelli A, Salvi M, Vignozzi L, Tubaro A, Morgia G, Serni S. Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis 20:146-155, 2017.
Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corcetto F, Corno C, Maneschi E, Pini A, Adorini L, Vannelli GB, Maggi M, Vignozzi L. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. J Steroid Biochem Mol Biol 168:26-37, 2017.
Comeglio P, Cellai I, Filippi S, Corno C, Corcetto F, Morelli A, Maneschi E, Maseroli E, Mannucci E, Fambrini M, Maggi M, Vignozzi L. Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats. J Sex Med 13:1858-1871, 2016.
Gacci M, Vignozzi L, Corona G, Serni S, Maggi M. Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 70:788-96, 2016. Eur Urol 71: e119-e120, 2017.
Maseroli E, Fanni E, Cipriani S, Scavello I, Pampaloni F, Battaglia C, Fambrini M, Mannucci E, Jannini EA, Maggi M, Vignozzi L. Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance. J Sex Med 13:1651-1661, 2016.
Sarchielli E, Comeglio P, Squecco R, Ballerini L, Mello T, Guarnieri G, Idrizaj E, Mazzanti B, Vignozzi L, Gallina P, Maggi M, Vannelli GB, Morelli A. Tumor Necrosis Factor-α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons. J Clin Endocrinol Metab 102:46-56, 2017.
Gacci M, Corona G, Sebastianelli A, Serni S, De Nunzio C, Maggi M, Vignozzi L, Novara G, McVary KT, Kaplan SA, Gravas S, Chapple C. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 70:788-796, 2016.
Gacci M, Sebastianelli A, Salvi M, De Nunzio C, Tubaro A, Gravas S, Moncada I, Serni S, Maggi M, Vignozzi L. The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery. Curr Urol Rep 17:61, 2016.
Vignozzi L, Morelli A, Cellai I, Filippi S, Comeglio P, Sarchielli E, Maneschi E, Vannelli GB, Adorini L, Maggi M. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. J Steroid Biochem Mol Biol 165:277-292, 2017.
Maseroli E, Fanni E, Mannucci E, Fambrini M, Jannini EA, Maggi M, Vignozzi L. Which are the male factors associated with female sexual dysfunction (FSD)? Andrology 4:911-20, 2016.
Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, Saad F, Mannucci E, Maggi M. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest 39:967-81, 2016.
Morelli A, Vignozzi L, Maggi M. Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model. Minerva Endocrinol 41:240-9, 2016.
Maneschi E, Cellai I, Aversa A, Mello T, Filippi S, Comeglio P, Bani D, Guasti D, Sarchielli E, Salvatore G, Morelli A, Mazzanti B, Corcetto F, Corno C, Francomano D, Galli A, Vannelli GB, Lenzi A, Mannucci E, Maggi M, Vignozzi L. Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. Mol Cell Endocrinol 424:50-70, 2016.
Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol 13:108-19, 2016.
Corona G, Bianchini S, Sforza A, Vignozzi L, Maggi M. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones (Athens) 14:569-78, 2015.
Rastrelli G, Vignozzi L, Maggi M. Different Medications for Hypogonadotropic Hypogonadism. Endocr Dev 30:60-78, 2016.
Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, Saad F, Mannucci E, Maggi M. Therapy of Endocrine Disease: Testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol 174:R99-116, 2016.
Maseroli E, Scavello I, Vignozzi L. Cardiometabolic Risk and Female Sexuality-Part I. Risk Factors and Potential Pathophysiological Underpinnings for Female Vasculogenic Sexual Dysfunction Syndromes. Sex Med Rev 6:508-524, 2018.
Maseroli E, Scavello I, Vignozzi L. Cardiometabolic Risk and Female Sexuality-Part II. Understanding (and Overcoming) Gender Differences: The Key Role of an Adequate Methodological Approach. Sex Med Rev. 6:525-534, 2018.
Traish AM, Vignozzi L, Simon JA, Goldstein I, Kim NN. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. Sex Med Rev 6:558-571, 2018.
Clayton AH, Goldstein I, Kim NN, Althof SE, Faubion SS, Faught BM, Parish SJ, Simon JA, Vignozzi L, Christiansen K, Davis SR, Freedman MA, Kingsberg SA, Kirana PS, Larkin L, McCabe M, Sadovsky R. The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women. Mayo Clin Proc 93:467-487, 2018.
Castellini G, Lelli L, Corsi E, Campone B, Ciampi E, Fisher AD, Mallardo L, Monteleone AM, Rotella F, Tofani T, Vignozzi L, Zamponi F, Maggi M, Ricca V. Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study. Psychother Psychosom 86:376-378, 2017.
Maseroli E, Scavello I, Cipriani S, Palma M, Fambrini M, Corona G, Mannucci E, Maggi M, Vignozzi L. Psychobiological Correlates of Vaginismus: An Exploratory Analysis. J Sex Med 14:1392-1402, 2017.
Comeglio P, Morelli A, Adorini L, Maggi M, Vignozzi L. Beneficial effects of bile acid receptor agonists in pulmonary disease models. Expert Opin Investig Drugs 26:1215-1228, 2017.
Rastrelli G, Vignozzi L, Corona G, Maggi M. Testosterone and Benign Prostatic Hyperplasia. Sex Med Rev 7:259-271, 2019.
Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corno C, Adorini L, Vannelli GB, Maggi M, Vignozzi L. Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. J Endocrinol Invest 42:951-965, 2019.
Morelli A, Filippi S, Comeglio P, Sarchielli E, Cellai I, Pallecchi M, Bartolucci G, Danza G, Rastrelli G, Corno C, Guarnieri G, Fuochi E, Vignozzi L, Maggi M. Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. Am J Physiol Endocrinol Metab 316: E519-E535, 2019.
Rastrelli G, Cipriani S, Corona G, Vignozzi L, Maggi M. Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. Andrology 7:163-171, 2019.
Vignozzi L, Malavolta N, Villa P, Mangili G, Migliaccio S, Lello S. Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO. J Endocrinol Invest 42:609-618, 2019.
Maseroli E, Scavello I, Campone B, Di Stasi V, Cipriani S, Felciai F, Camartini V, Magini A, Castellini G, Ricca V, Maggi M, Vignozzi L. Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span. J Sex Med 15:1739-1751, 2019.
Maseroli E, Scavello I, Rastrelli G, Limoncin E, Cipriani S, Corona G, Fambrini M, Magini A, Jannini EA, Maggi M, Vignozzi L. Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. J Sex Med 15:1752-1764, 2018.
Mollaioli D, Di Sante S, Limoncin E, Ciocca G, Gravina GL, Maseroli E, Fanni E, Vignozzi L, Maggi M, Lenzi A, Jannini EA. Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F. PLoS One. 13: e0202076, 2018.
Comeglio P, Cellai I, Mello T, Filippi S, Maneschi E, Corcetto F, Corno C, Sarchielli E, Morelli A, Rapizzi E, Bani D, Guasti D, Vannelli GB, Galli A,Adorini L, Maggi M, Vignozzi L. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. J Endocrinol 238:107-127, 2018.
Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corno C, Pini A, Adorini L, Vannelli GB, Maggi M, Vignozzi L. Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model. J Endocrinol Invest 42:283-294, 2019.
Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause 25:837-847, 2018.
Corona G, Isidori AM, Aversa A, Bonomi M, Ferlin A, Foresta C, La Vignera S, Maggi M, Pivonello R, Vignozzi L, Lombardo F. Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs Rev Endocr Metab Disord 21:57-65, 2020.
Vignozzi L and Reisman Y. Testosterone in women: are we closing the gender gap? Nat Rev Urol 17:67-68, 2020.
Corona G, Minhas S, Giwercman A, Bettocchi C, Dinkelman-Smit M, Dohle G, Fusco F, Kadioglou A, Kliesch S, Kopa Z, Krausz C, Pelliccione F, Pizzocaro A, Rassweiler J, Verze P, Vignozzi L, Weidner W, Maggi M, Sofikitis N. Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis. Hum Reprod Update 25:733-757, 2019.
Both S, Lew-Starowicz M, Luria M, Sartorius G, Maseroli E, Tripodi F, Lowenstein L, Nappi RE, Corona G, Reisman Y, Vignozzi L. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM) J Sex Med 16:1681-1695, 2019.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton JA, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab 104:4660-4666, 2019.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton JA, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Sex Med 16:1331-1337, 2019.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton JA, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global Consensus Position Statement on the use of Testosterone Therapy for Women. Maturitas 128:89-93, 2019.
Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Sexual Health in Menopause. Medicina (Kaunas). 55:559, 2019.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton JA, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global Consensus Position Statement on the use of Testosterone Therapy for Women. Climacteric 22:429-434, 2019.
Marchiani S, Tamburrino L, Farnetani G, Muratori M, Vignozzi L, Baldi E. Acute effects on human sperm exposed in vitro to cadmium chloride and diisobutyl phthalate. Reproduction 158:281-290, 2019.
Rastrelli G, Vignozzi L, Maggi M. Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? Asian J Androl 22:233-235, 2020.
Sebastianelli A, Spatafora P, Frizzi J, Saleh O, Sessa M, De Nunzio C, Tubaro A, Vignozzi L, Maggi M, Serni S, McVary KT, Kaplan SA, Gravas S, Chapple C, Gacci M. Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. J Clin Med 8:1126, 2019.
Scavello I, Maseroli E, Di Stasi V, Cipriani S, Verde N, Magini A, Maggi M, Vignozzi L. Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study. Int J Impot Res 32:239-247, 2020.
Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, Donini LM, Basciani S, Cignarelli A, Conte E, Ceccarini G, Bogazzi F, Cimino L, Condorelli RA, La Vignera S, Calogero AE, Gambineri A, Vignozzi L, Prodam F, Aimaretti G, Linsalata G, Buralli S, Monzani F, Aversa A, Vettor R, Santini F, Vitti P, Gnessi L, Pagotto U, Giorgino F, Colao A, Lenzi A. Cardiovascular Endocrinology Club of the Italian Society of Endocrinology. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest 42:1365-1386, 2019.
Balercia G, Bonomi M, Giagulli VA, Lanfranco F, Rochira V, Giambersio A, Accardo G, Esposito D, Allasia S, Cangiano B, De Vincentis S, Condorelli RA, Calogero A, Pasquali D, KING group (including Vignozzi L). Thyroid function in Klinefelter syndrome: a multicentre study from KING group. J Endocrinol Invest 42:1199-1204, 2019.
Corona G, Salvi M, Sebastianelli A, Bossa R, Vignozzi L, Maggi M, De Nunzio C, Serni S, Gratzke C, Gravas S, Gacci M. Role of prostate specific antigen and prostate specific antigen density as biomarkers for medical and surgical treatment response in men with lower urinary tract symptoms. Minerva Urol Nefrol 72:135-43, 2020.
Cocchetti C, Ristori J, Mazzoli F, Prunas A, Bertelloni S, Magini A, Vignozzi L, Maggi M, Fisher AD. 5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature. J Endocrinol Invest 43:1131-1136, 2020.
Rowen TS, Davis SR, Parish S, Simon J, Vignozzi L. Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women. J Sex Med 17:585-94, 2020.
Maseroli E, Santangelo A, Lara-Fontes B, Quintana GR, Mac Cionnaith CE, Casarrubea M, Ricca V, Maggi M, Vignozzi L, Pfaus JG. The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol. Psychoneuroendocrinology 115:104606, 2020.
Ristori J, Cocchetti C, Romani A, Mazzoli F, Vignozzi L, Maggi M, Fisher AD. Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? Int J Mol Sci 21:2123, 2020.
Maggi M, Filippi S, Vignozzi L, Rastrelli G. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism. Andrology 8:1580-1589, 2020.
Salonia A, Corona G, Giwercman A, Maggi M, Minhas S, Nappi RE, Sofikitis N, Vignozzi L. SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project. Andrology 9:19-22, 2021.
Maseroli E, Vignozzi L. Testosterone and Vaginal Function. Sex Med Rev 8:379-392, 2020.
Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, Spreafico F, Greco GF, Cervi G, Pecoriello A, Magini A, Todisco T, Cipriani S, Maseroli E, Corona G, Salonia A, Lenzi A, Maggi M, De Donno G, Vignozzi L. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology 9:88-98, 2021
Cassioli E, Rossi E, Squecco R, Baccari MC, Maggi M, Vignozzi L, Comeglio P, Gironi V, Lelli L, Rotella F, Monteleone AM, Ricca V, Castellini G. Reward and psychopathological correlates of eating disorders: The explanatory role of leptin. Psychiatry Res 290:113071, 2020.
Fisher AD, Ristori J, Castellini G, Cocchetti C, Cassioli E, Orsolini S, Sensi C, Romani A, Mazzoli F, Cipriani A, Ricca V, Vignozzi L, Viggiano MP, Mascalchi M, Maggi M, Gavazzi G. Neural Correlates of Gender Face Perception in Transgender People. J Clin Med 9:1731, 2020.
Cipriani S, Todisco T, Scavello I, Di Stasi V, Maseroli E, Vignozzi L. Obesity and hormonal contraception: an overview and a clinician's practical guide. Eat Weight Disord 25:1129-1140, 2020.
Corona G, Rastrelli G, Morelli A, Sarchielli E, Cipriani S, Vignozzi L, Maggi M. Treatment of Functional Hypogonadism Besides Pharmacological Substitution. World J Mens Health 38:256-270, 2020.
Franchini M, Glingani C, Del Fante C, Capuzzo M, Di Stasi V, Rastrelli G, Vignozzi L, De Donno G, Perotti C. The protective effect of O blood type against SARS-CoV-2 infection. Vox Sang 116:249-250, 2021.
Ristori J, Cocchetti C, Castellini G, Pierdominici M, Cipriani A, Testi D, Gavazzi G, Mazzoli F, Mosconi M, Meriggiola MC, Cassioli E, Vignozzi L, Ricca V, Maggi M, Fisher AD. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data. J Sex Med 17:142-151, 2020
Maseroli E, Cellai I, Filippi S, Comeglio P, Cipriani S, Rastrelli G, Rosi M, Sorbi F, Fambrini M, Petraglia F, Amoriello R, Ballerini C, Lombardelli L, Piccinni MP, Sarchielli E, Guarnieri G, Morelli A, Maggi M, Vignozzi L. Anti-inflammatory effects of androgens in the human vagina. J Mol Endocrinol 65:109-124, 2020.
Sebastianelli A, Spatafora P, Morselli S, Vignozzi L, Serni S, McVary KT, Kaplan S, Gravas S, Chapple C, Gacci M.Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED. Curr Urol Rep 21:56, 2020.
Sarchielli E, Comeglio P, Filippi S, Cellai I, Guarnieri G, Guasti D, Rapizzi E, Rastrelli G, Bani D, Vannelli G, Vignozzi L, Morelli A, Maggi M. Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. J Endocrinol 245:259-279, 2020.
Corona G, Salvi M, Sebastianelli A, Bossa R, Vignozzi L, Maggi M, De Nunzio C, Serni S, Gratzke C, Gravas S, Gacci M. Role of prostate specific antigen and prostate specific antigen density as biomarkers for medical and surgical treatment response in men with lower urinary tract symptoms. Minerva Urol Nefrol 72:135-143, 2020.
Vignozzi L, Maggi M. Circadian rhythm and erectile function: is there a penile clock? Nat Rev Urol 17:603-604, 2020.
Marchiani S, Tamburrino L, Benini F, Pallecchi M, Bignozzi C, Conforti A, Alviggi C, Vignozzi L, Danza G, Pellegrini S, Baldi E. LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women. Sci Rep 10:12907, 2020.
Di Maida F, Vittori G, Campi R, Mari A, Tellini R, Sforza S, Sessa F, Lucarini S, Miele V, Vignozzi L, Masieri L, Carini M, Minervini A. Clinical predictors and significance of adherent perinephric fat assessed with Mayo Adhesive Probability (MAP) score and Perinephric Fat Surface Density (PnFSD) at the time of partial nephrectomy for localized renal mass. A single high-volume referral centre experience. Minerva Urol Nefrol 73:225-232, 2021.
Sebastianelli A, Morselli S, Spatafora P, Liaci A, Gemma L, Zaccaro C, Vignozzi L, Maggi M, McVary KT, Kaplan SA, Chapple C, Gravas S, Serni S, Gacci M. Outcomes of combination therapy with daily Tadalafil 5mg plus Tamsulosin 0.4mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome. Minerva Urol Nefrol 76: 836-844, 2021.
Sarchielli E, Comeglio P, Filippi S, Cellai I, Guarnieri G, Marzoppi A, Cipriani S, Vignozzi L, Morelli A, Maggi M. Neuroprotective Effects of Testosterone in the Hypothalamus of an Animal Model of Metabolic Syndrome. Int J Mol Sci 22:1589, 2021.
Cocchetti C, Ristori J, Mazzoli F, Vignozzi L, Maggi M, Fisher AD Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. Int J Impot Res 33: 703-709, 2020.
Comeglio P, Sarchielli E, Filippi S, Cellai I, Guarnieri G, Morelli A, Rastrelli G, Maseroli E, Cipriani S, Mello T, Galli A, Bruno BJ, Kim K, Vangara K, Papangkorn K, Chidambaram N, Patel MV, Maggi M, Vignozzi L. Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. J Endocrinol Invest 44:2175-2193, 2021.
Gacci M, Coppi M, Baldi E, Sebastianelli A, Zaccaro C, Morselli S, Pecoraro A, Manera A, Nicoletti R, Liaci A, Bisegna C, Gemma L, Giancane S, Pollini S, Antonelli A, Lagi F, Marchiani S, Dabizzi S, Degl'Innocenti S, Annunziato F, Maggi M, Vignozzi L, Bartoloni A, Rossolini GM, Serni S. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum Reprod 36:1520-1529, 2021.
Cellai I, Di Stasi V, Comeglio P, Maseroli E, Todisco T, Corno C, Filippi S, Cipriani S, Sorbi F, Fambrini M, Petraglia F, Scavello I, Rastrelli G, Acciai G, Villanelli F, Danza G, Sarchielli E, Guarnieri G, Morelli A, Maggi M, Vignozzi L. Insight on the Intracrinology of Menopause: Androgen Production within the Human Vagina. Endocrinology 1;162: bqaa219, 2021.
Sebastianelli A, Spatafora P, Frizzi J, Saleh O, De Nunzio C, Tubaro A, Vignozzi L, Maggi M, Serni S, McVary KT, Kaplan SA, Gravas S, Chapple C, Gacci M. Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial. Eur Urol Focus 7:432-439, 2021.
Ristori J, Rossi E, Cocchetti C, Mazzoli F, Castellini G, Vignozzi L, Ricca V, Maggi M, Fisher AD.Sexual habits among Italian transgender adolescents: a cross-sectional study. Int J Impot Res 33: 687-693, 2020.
Di Stasi V, Maseroli E, Rastrelli G, Scavello I, Cipriani S, Todisco T, Marchiani S, Sorbi F, Fambrini M, Petraglia F, Maggi M, Vignozzi L. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Front Endocrinol (Lausanne) 12:641446, 2021.
Franchini M, Glingani C, Morandi M, Corghi G, Cerzosimo S, Beduzzi G, Storti A, Di Stasi V, Rastrelli G, Vignozzi L, Mengoli C, Garuti M, Beccaria M, Inglese F, Caruso B, Petilino RA, Amato M, Nicchio M, Pagani M, Bellani A, Castelli G, Casari S, De Donno G. Safety and efficacy of convalescent plasma in elderly COVID-19 patients: the RESCUE trial. Mayo Clin Proc Innov Qual Outcomes 5:403-412, 2021.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J. Womens Health (Larchmt) 30:474-491, 2021.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Climacteric 1:1-18, 2021.
Maseroli E, Comeglio P, Corno C, Cellai I, Filippi S, Mello T, Galli A, Rapizzi E, Presenti L, Truglia MC, Lotti F, Facchiano E, Beltrame B, Lucchese M, Saad F, Rastrelli G, Maggi M, Vignozzi L. Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. J Endocrinol Invest 44:819-842, 2021.
Cocchetti C, Castellini G, Iacuaniello D, Romani A, Maggi M, Vignozzi L, Schreiner T, den Heijer M, T'Sjoen G, Fisher AD.Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI). J Sex Med 8:821-829, 2021.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J Sex Med 18:849-867, 2021.
Zaccaro C, Lotti F, Morselli S, Sebastianelli A, Frizza F, Bigazzi B, Liaci A, Cai T, Vignozzi L, Vignolini G, Serni S, Gravas S, Moncada I, Salonia A, Gacci M. SECRET<sup>®</sup> - SExual Chronicle REcording Table: Validation and reliability. Andrology 9:878-885, 2021.
Cipriani S, Todisco T, Ghiandai N, Vignozzi L, Corona G, Maggi M, Rastrelli G, Biochemical predictors of structural hypothalamus-pituitary abnormalities detected by magnetic resonance imaging in men with secondary hypogonadism. J. Endocrinol Invest 44: 2785-2797, 2021.
Yannas, D, Frizza, F, Vignozzi L, Corona, G, Maggi, M. Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men's Health? J Clin Med 10:2221, 2021.
Corona G, Filippi S, Comeglio P, Bianchi N, Frizza F, Dicuio M, Rastrelli G, Concetti S, Sforza A, Vignozzi L, Maggi M.Sexual function in men undergoing androgen deprivation therapy. Int J Impot Res 33:439-447, 2021.
Gacci M, Coppi M, Baldi E, Sebastianelli A, Zaccaro C, Morselli S, Pecoraro A, Manera A, Nicoletti R, Liaci A, Bisegna C, Gemma L, Giancane S, Pollini S, Antonelli A, Lagi F, Marchiani S, Dabizzi S, Nicolò S, Torcia M, Degl'innocenti S, Annunziato F, Maggi M, Vignozzi L, Bartoloni A, Rossolini GM, Serni S. Reply: COVID-19: semen impairment may not be related to the virus. Hum Reprod 36:2065-2066, 2021.
Corona G, Rastrelli G, Marchiani S, Filippi S, Morelli A, Sarchielli E, Sforza A, Vignozzi L, Maggi M. Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective. World J Mens Health 40: 165-178, 2022.
Cipriani S, Maseroli E, Di Stasi V, Scavello I, Todisco T, Rastrelli G, Fambrini M, Sorbi F, Petraglia F, Jannini EA, Maggi M, Vignozzi L. Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction. J Endocrinol Invest 44: 2765-2776, 2021.
Corona G, Rastrelli G, Vignozzi L, Barbonetti A, Sforza A, Mannucci E, Maggi M. The Role of testosterone treatment in patients with metabolic disorders. Expert Rev Clin Pharmacol. 14: 1091-1103, 2021.
Maseroli E, Rastrelli G, Di Stasi V, Cipriani S, Scavello I, Todisco T, Gironi V, Castellini G, Ricca V, Sorbi F, Fambrini M, Petraglia F, Maggi M, Vignozzi L. Physical Activity and Female Sexual Dysfunction: A Lot Helps, But Not Too Much. J Sex Med 18:1217-1229, 2021.
Rossi E, Cassioli E, Gironi V, Idrizaj E, Garella R, Squecco R, Baccari MC, Maggi M, Vignozzi L, Comeglio P, Ricca V, Castellini G. Ghrelin as a possible biomarker and maintaining factor in patients with eating disorders reporting childhood traumatic experiences. Eur Eat Disord Rev 29:588-599, 2021.
Guarnieri G, Becatti M, Comeglio P, Vignozzi L, Maggi M, Vannelli GB, Morelli A. Benzo[a]pyrene impairs the migratory pattern of human gonadotropin-releasing-hormone-secreting neuroblasts. Eur J Histochem 65(s1)3282, 2021.
Marchiani S, Baccani I, Tamburrino L, Mattiuz G, Nicolò S, Bonaiuto C, Panico C, Vignozzi L, Antonelli A, Rossolini G, Torcia M, Baldi E. Effects of common Gram-negative pathogens causing male genitourinary-tract infections on human sperm functions. Sci Rep 11:19177, 2021.
Scavello I, Maseroli E, Cipriani S, Di Stasi V, Verde N, Menafra D, Scannerini S, Marchiani S, Rastrelli G, Ricca V, Sorbi F, Fambrini M, Petraglia F, Maggi M, Vignozzi L. Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms. Sci Rep 11:18899, 2021.
Riley L, Ammar O, Mello T, Giovannelli L, Vignozzi L, Muratori M. Novel methods to detect ROS in viable spermatozoa of native semen samples. Reprod Toxicol 106: 51-60, 2021.
Di Stasi V, Rastrelli G, Inglese F, Beccaria M, Garuti M, Di Costanzo D, Spreafico F, Cervi G, Greco GF, Pecoriello A, Todisco T, Cipriani S, Maseroli E, Scavello I, Glingani C, Franchini M, Maggi M, De Donno G, Vignozzi L. Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study. J Endocrinol Invest 45: 639-648, 2022.
Romani A, Mazzoli F, Ristori J, Cocchetti C, Cassioli E, Castellini G, Mosconi M, Meriggiola MC, Gualdi S, Giovanardi G, Lingiardi V, Vignozzi L, Maggi M, Fisher AD. Psychological Wellbeing and Perceived Social Acceptance in Gender Diverse Individuals. J Sex Med 18:1933-1944, 2021.
Di Stasi V, Maseroli E, Vignozzi L. Female Sexual Dysfunction in Diabetes: Mechanisms, Diagnosis and Treatment. Curr Diabetes Rev 18: e171121198002, 2022.
Morselli S, Sebastianelli A, Liaci A, Zaccaro C, Pecoraro A, Nicoletti R, Manera A, Bisegna C, Campi R, Pollini S, Antonelli A, Lagi F, Coppi M, Baldi E, Marchiani S, Nicolò S, Torcia M, Annunziato F, Maggi M, Vignozzi L, Bartoloni A, Rossolini GM, Serni S, Gacci M. Male reproductive system inflammation after healing from coronavirus disease 2019. Andrology 10: 1030-1037, 2022.
Serefoglu EC, Reisman Y, Bitzer J, Vignozzi L, Jannini EA. The only available certification for sexual medicine: The Fellow of the European Committee Sexual Medicine (FECSM). Int J Impot Res 2021 Dec 1. [Epub ahead of print]
Corona G, Vena W, Pizzocaro A, Giagulli VA, Francomano D, Rastrelli G, Mazziotti G, Aversa A, Isidori AM, Pivonello R, Vignozzi L, Mannucci E, Maggi M, Ferlin A. Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest 45: 911-926, 2022.
Cassioli E, Rossi E, Vizzotto C, Malinconi V, Vignozzi L, Ricca V, Castellini G. Avoidant Attachment Style Moderates the Recovery of Healthy Sexuality in Women With Anorexia Nervosa Treated With Enhanced Cognitive Behavior Therapy (CBT-E): A 2-Year Follow-Up Study. J Sex Med 19: 347-335, 2022.
Cellai I, Filippi S, Comeglio P, Cipriani S, Maseroli E, Di Stasi V, Todisco T, Marchiani S, Tamburrino L, Villanelli F, Vezzani S, Corno C, Fambrini M, Guarnieri G, Sarchielli E, Morelli A, Rastrelli G, Maggi M, Vignozzi L. Testosterone positively regulates vagina NO-induced relaxation: an experimental study in rats. J Endocrinol Invest 45: 1161-1172, 2022.
Marchiani S, Dabizzi S, Degl'Innocenti S, Fino MG, Torcia MG, Paoli D, Lombardo F, Ciccone N, Pollini S, Rossolini GM, Vignozzi L, Krausz C, Baldi E. Safety issues in semen banks during the COVID-19 pandemic: data from a European survey. J Endocrinol Invest 45: 973-980, 2022.
Rastrelli G, Cipriani S, Lotti F, Cellai I, Comeglio P, Filippi S, Boddi V, Della Camera PA, Santi R, Boni L, Nesi G, Serni S, Gacci M, Maggi M, Vignozzi L. Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial. J Endocrinol Invest 45: 1413-1425, 2022.
Corona G, Rastrelli G, Vignozzi L, Maggi M. Androgens and male sexual function. Best Pract Res Clin Endocrinol Metab 36:101615, 2022.
Maseroli E, Vignozzi L. Are Endogenous Androgens Linked to Female Sexual Function? A Systemic Review and Meta-Analysis. J Sex Med 219: 553-568, 2022.
Corona G, Vena W, Pizzocaro A, Pallotti F, Paoli D, Rastrelli G, Baldi E, Cilloni N, Gacci M, Semeraro F, Salonia A, Minhas S, Pivonello R, Sforza A, Vignozzi L, Isidori AM, Lenzi A, Maggi M, Lombardo F. Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. J Endocrinol Invest. 2022 May 9:1–13. [Epub ahead of print].
Cocchetti C, Baldinotti F, Romani A, Ristori J, Mazzoli F, Vignozzi L, Maggi M, Fisher AD. A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46XY Difference of Sexual Development. Sex Med. 2022 May 16;10(4):100522 [Epub ahead of print]
Pasquali D, Chiodini P, Simeon V, Ferlin A, Vignozzi L, Corona G, Lanfranco F, Rochira V, Calogero AE, Bonomi M, Pivonello R, Balercia G, Pizzocaro A, Giagulli VA, Salacone P, Aversa A, Accardo G, Maggi M, Lenzi A, Isidori A, Foresta C, Jannini EA, Garolla A; KING, Klinefelter ItaliaN Group. First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy. J Endocrinol Invest 45:1769-1776, 2022.
Cocchetti C, Romani A, Mazzoli F, Ristori J, Lagi F, Meriggiola MC, Motta G, Pierdominici M, Bartoloni A, Vignozzi L, Maggi M, Fisher AD. Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study. J Clin Med. 11(10):2774, 2022.
Arciero V, Ammar O, Maggi M, Vignozzi L, Muratori M, Dabizzi S. Vapour fast freezing with low semen volumes can highly improve motility and viability or DNA quality of cryopreserved human spermatozoa. Andrology 10:1123-1133, 2022.
Mazzoli F, Cassioli E, Ristori J, Castellini G, Rossi E, Cocchetti C, Romani A, Angotti T, Giovanardi G, Mosconi M, Lingiardi V, Speranza AM, Ricca V, Vignozzi L, Maggi M, Fisher AD. Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment. J Endocrinol Invest 45:2059-2067, 2022.
Chapter of scientific books
1) A. Morelli, L. Vignozzi, R. Mancina, S. Filippi, M. Luconi, M. Marini, G. Forti, M. Maggi, “Regolazione androgenica dell’espressione genica e dell’attività di PDE5”; in: C. Foresta, A. Ferlin, Andrologia e riproduzione, Cleup Editrice, Padova, 2004.
2) Morelli A., Zhang X.H., Vignozzi L., Filippi S., Mancina R., Maggi M., “Studi sperimentali di interazione tra inibitori della PDE5 e androgeni”; in: C. Foresta, A. Lenzi, A. Ferlin, Le alterazioni gonadiche: aspetti fisiologici e clinici, Cleup Editrice, Padova, 2005.
3) Morelli A, Vignozzi L, Filippi S, Mancina R, Lotti F, Maggi M., “Aspetti fisiopatologici e clinici della disfunzione erettile”; in: Fisiopatologia della riproduzione, Casa Editrice CIC Edizioni Internazionali, Roma, 2006.
4) Vignozzi L, Morelli A, Filippi S, Mancina R., “Fisiologia dell’erezione”, cap. 25, pp: 105-113; in: E. Jannini, A. Lenzi, M. Maggi, Trattato di Sessuologia Medica, Ed. Elsevier Masson, Milano, 2007.
5) Vignozzi L, Maggi M, Forti G., “Malattie del testicolo”; in: Malattie del sistema endocrino e del metabolismo, Ed. Piccin, Padova, 2008.
6) Jannini EA, Maggi M, Vignozzi L, Lenzi A., “Advances in the mechanism of ejaculation”; in: Advances in sexual medicine. Research Signpost, Transworld Research Network, Kerala, India 2008.
7) Vignozzi L, Forti G., “Anatomia e fisiologia riproduttiva maschile”, cap.3, pp:15-25; in: Guida allo studio dell’andrologia, Società Editrice Universo, Roma, 2012.
8) Vignozzi L, Maggi M, Corona G., “Sexuality and Childhood”, cpt. 7, pp: 149-175, in: The ESSM Syllabus of Sexual Medicine, MediX Publisher, Amsterdam, 2012.
9) Cipriani S., Maseroli E., Vignozzi L., “Testosterone in Females”, cpt. 8, pp: 81-105, in: Mulhall J.P., Maggi M., Trost L. (eds), Controversies in Testosterone Deficiency, Springer, Cham (CH), 2021.
Papers published in indexed journals concerning pedagogy in the health and medical field
1) Pietro Gallo, Isabella Barajon, Stefania Basili, Fabrizio Consorti, Carlo della Rocca, Giuseppe Familiari, Giovanni Ferraiuoli, Fausta Lui, Manuela Merli, Bruno Moncharmont, Oliviero Riggio, Maria Grazia Strepparava, Maurizia Valli e Linda Vignozzi. La CTP 2.0 – Nuove linee-guida della CPPCCLM in Medicina per la creazione e il funzionamento di una CTP (Metodologia). n.84, 2019, pp. 3733-3736, DOI: 10.4487/medchir2019-84-1. Pubblicato Ottobre 2020. La CTP 2.0 - Nuove linee-guida della CPPCCLM in Medicina per la creazione e il funzionamento di una CTP (Metodologia) - Medicina e Chirurgia - Journal of Italian Medical Education (quaderni-conferenze-medicina.it).
2) Paolo Villari, Pasquale Abete, Giuseppe Gallina, Giuseppe Santoro, Isabella Barajon, Gianpaolo Papaccio, Maria Grazia Strepparava, Edoardo Spina, Antonio Moschetta, Davide Trerè, Trevisani Franco, Luigi Rondella, Stefano Marini, Andrea Figus, Agostino Palmeri, Agostino Gnasso, Raffaella Muraro, Tiziana Bellini, Domenico Prisco, Maria Filomena Caiaffa, Marco Frascio, Marco Ferrario, Leila Fabiani, Giovanni Montini, Manuela Nebuloni, Giulia Morace, Gabriella Cerri, Vittorio Locatelli, Antonio Lanzone, Luca Richeldi Francesco Maria Bandello, Claudio Doglioni, Fausta Lui, Mariano Intrieri, Sabino De Placido, Francesco Catapano, Marcellino Monda, Maria Luigia Randi, Lorella Franzoni, Patrizia Noris, Monica Galliano, Francesco Grignani, Sandra D’Alfonso, Riccardo Ruffoli, Cristina Marmorale, Giuseppe Familiari, Antonio Angeloni, Manuela Merli, Roberta Misasi, Stefania Basili, Oliviero Riggio, Gianfranco Bosco, Daniele Santini, Paolo Pozzillo, Marcello Persico, Paolo Castiglia, M. Graziella De Montis, Roberta Siliquini, David Lembo, Roberto Luzzati, Bruno Grassi, Corrado Barbui, Bruno Moncharmont, Amos Casti, Linda Vignozzi, Andrea Lenzi, Roberto Monaco, Roberto Stella, Filippo Anelli. Evaluation of the clinical clerkship for the Medical License in Italy. Evaluation of the clinical clerkship for the Medical License in Italy - Medicina e Chirurgia - Journal of Italian Medical Education (quaderni-conferenze-medicina.it).
3) Bruno Moncharmont, Giuseppe Familiari, Linda Vignozzi, Carlo della Rocca, Andrea Lenzi, e Stefania Basili. Dal nuovo “esame di Stato” alla “laurea abilitante” n.85, 2020, pp. 3747-3751, DOI: 10.4487/medchir2020-85-1. Pubblicato Dicembre 2020. Dal nuovo "esame di Stato" alla "laurea abilitante" - Medicina e Chirurgia - Journal of Italian Medical Education (quaderni-conferenze-medicina.it).
4) Giuseppe Familiari, Bruno Moncharmont, Linda Vignozzi, Carlo della Rocca, Andrea Lenzi, e Stefania Basili. La modifica dell’ordinamento didattico della classe di laurea magistrale LM/41: non solo adempimenti burocratici, ma anche innovazione n.85, 2020, pp. 3752-3758, DOI: 10.4487/medchir2020-85-2 Pubblicato Dicembre 2020. La modifica dell'ordinamento didattico della classe di laurea magistrale LM/41: non solo adempimenti burocratici, ma anche innovazione - Medicina e Chirurgia - Journal of Italian Medical Education (quaderni-conferenze-medicina.it).
5) B. Moncharmont, F. Consorti, G. Familiari, P. Gallo, M. Krengli, M. L. Randi, M. G. Strepparava, L. Vignozzi, M. Sabella, M. R. Infurna e S. BasiliIl Test sulle Competenze (TECO) dell’ANVUR: prima applicazione ai corsi di laurea magistrale in Medicina e Chirurgia“, n 86, 2021 pp 3823-3825 Pubblicato Novembre 2021. Il Test sulle Competenze (TECO) dell’ANVUR: prima applicazione ai corsi di laurea magistrale in Medicina e Chirurgia - Medicina e Chirurgia - Journal of Italian Medical Education (quaderni-conferenze-medicina.it).
Legenda
Brief Description: Linda Vignozzi is Associate Professor in Endocrinology at the University of Florence, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”; she coordinates the Gynaecological Endocrinology Research Unit; She is Directore of the SODc (complex organizational departmental structure) Andrology, Women's Endocrinology and Geneder Incongruence-Careggi Hospital, University of Florence, Florence, Italy; accreditated training center of the European Accademy of Andrology, reference regional center for diagnosis and therapy of erectile dysfunction, reference regional center for semen cryopreservetion. She is deputy-Director of the Department of Experimental and Biomedical sciences “Mario Serio”. At the University of Florence she received the MD and the PhD degree in Endocrinology and Metabolic diseases. At the School of Endocrinology and Metabolism- University of Pisa, she received her Postgraduate Diplomate (2011). Since July 2015 she is Associate Professor of Endocrinology at the Medical School of the University of Florence. Prof. Linda Vignozzi (orcid.org/0000-0003-0907-0630) is the co-author of more than 222 manuscripts ( H-index Scopus 60; Author ID: 6507526011 ), has written several book chapters and invited reviews in the field of male and female sexual medicine, hypogonadism and metabolic diseases, prostatic diseases, including BPH, human reproduction. Prof. Linda Vignozzi was a member of the Scientific Committee of the Italian Society of Andrology and Sexual Medicine (2009-2012), member of the Executive Committee of the Italian Society of Andrology and Sexual Medicine (2012-2016), member of the Scientific Committee of the Italian Society of Obesity (SIO; 2014-2018) and a member of the Scientific committee of the Italian Society of Endocrinology (SIE; 2015 -2017). She is currently a member of the Executive Committee of the Italian Society of Endocrinology, a ; the Chair of “Female Sexual (dys)function” scientific subcommittee of the International Society for Sexual Medicine and also Chair of “Female sexual health and dysfunction” scientific subcommittee of the European Society for Sexual Medicine (ESSM). In addition she coordinated the Committee dedicated to “Endocrinology and Female Sexuality “of the Italian Society of Andrology and Sexual Medicine (SIAMS). She is currently President Elect of the Italian Society of Andrology and Sexual Medicine (SIAMS); President Elect of the International Society for the study of women's sexual health (ISSWSH).